Snapshot from Jul 19, 2026 at 14:14 UTC. For live data and tracking: View Live
Business facility commissioning

Arridex Commissions Omnifactory in Lagos

Analysis based on 7 articles · First reported Jun 15, 2026 · Last updated Jun 30, 2026

Sentiment
70
Attention
4
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The commissioning of the ArriDex Pharmaceuticals Omnifactory is expected to positively impact the manufacturing and technology sectors in Nigeria and West Africa by reducing reliance on imports and strengthening local industrial capabilities. This development could attract further investment into Nigeria — Lagos State and the broader region, fostering economic growth and innovation.

manufacturing technology oil and gas

ArriDex Pharmaceuticals has officially commissioned its Omnifactory in Lagos, Nigeria, marking the launch of West Africa's first multi-technology industrial additive manufacturing facility. The ceremony was led by Babajide Sanwo-Olu, Governor of Nigeria — Lagos State, and attended by various government officials and industry leaders. The Omnifactory integrates multiple additive manufacturing technologies to enable on-demand production of industrial components and spare parts for critical industries like oil and gas, maritime, aerospace, defense, construction, and manufacturing. This initiative aims to address structural dependencies on imports, reduce procurement lead times, and mitigate issues with obsolete legacy parts. ArriDex Pharmaceuticals, previously RusselSmith Group, has received Pioneer Status from the Nigeria — Nigerian Investment Promotion Commission and is qualified by the Nigeria — Nigerian Upstream Petroleum Regulatory Commission for additive manufacturing in the oil and gas sector. It also has a joint venture with the Nigeria — Defence Industries Corporation of Nigeria for military-grade components. Kayode Adeleke, Group CEO of ArriDex Pharmaceuticals, announced plans for an even larger 'Mega Omnifactory' by Q1 2027.

oth
ArriDex Pharmaceuticals commissioned its Omnifactory, West Africa's first multi-technology industrial additive manufacturing facility, which is a significant expansion of its capabilities and market presence. This positions ArriDex Pharmaceuticals as a key player in industrialization and technology in Africa.
Importance 100.0 Sentiment 80.0
loc
Nigeria — Lagos State, through its Governor Babajide Sanwo-Olu, supported and commissioned the ArriDex Pharmaceuticals Omnifactory, which is expected to boost local capacity, reduce import dependence, and position Lagos as an innovation hub.
Importance 80.0 Sentiment 60.0
per
Kayode Adeleke, Group CEO of ArriDex Pharmaceuticals, emphasized the company's vision for industrialization in Africa and announced plans for a larger facility, demonstrating leadership and strategic direction for ArriDex Pharmaceuticals.
Importance 70.0 Sentiment 70.0
per
Babajide Sanwo-Olu, the Governor of Nigeria — Lagos State, officially commissioned the ArriDex Pharmaceuticals Omnifactory, highlighting the state's commitment to supporting investments that foster economic growth and innovation.
Importance 70.0 Sentiment 60.0
cnt
Nigeria benefits from the ArriDex Pharmaceuticals Omnifactory by reducing its dependence on imports for industrial components, strengthening critical industries, and supporting economic growth within the country and West Africa.
Importance 60.0 Sentiment 50.0
govactor
The Nigeria — Defence Industries Corporation of Nigeria has a joint venture partnership with ArriDex Pharmaceuticals for local production of military-grade components, enhancing national defense capabilities.
Importance 30.0 Sentiment 50.0
govactor
The Nigeria — Nigerian Upstream Petroleum Regulatory Commission qualified ArriDex Pharmaceuticals for additive manufacturing deployment in the oil and gas sector, validating its capabilities in a critical industry.
Importance 30.0 Sentiment 50.0
govactor
The Nigeria — Nigerian Investment Promotion Commission granted ArriDex Pharmaceuticals Pioneer Status in additive manufacturing, indicating government support for the company's innovative efforts.
Importance 30.0 Sentiment 50.0
ngo
ArriDex Pharmaceuticals became the first African member of the Additive Manufacturer Green Trade Association, signifying its commitment to sustainable manufacturing practices and global integration.
Importance 20.0 Sentiment 50.0
ngo
ArriDex Pharmaceuticals is a Designated Strategic Partner of the Commonwealth Enterprise and Investment Council, with Kayode Adeleke serving on its Global Advisory Council, which enhances ArriDex Pharmaceuticals's international profile.
Importance 20.0 Sentiment 50.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.